{"id":332744,"date":"2026-10-29T16:57:11","date_gmt":"2026-10-29T11:27:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q2-results-fy27-pat-31-crore\/"},"modified":"2026-10-29T16:57:11","modified_gmt":"2026-10-29T11:27:11","slug":"ind-swift-laboratories-q2-results-fy27-pat-31-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q2-results-fy27-pat-31-crore\/","title":{"rendered":"Ind-Swift Laboratories Q2 Results FY27: Standalone PAT Jumps 254.22% to Rs 31.03 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Ind-Swift Laboratories Q2 Results FY27 were declared on 29 October 2026, and the standalone quarterly results show revenue of Rs 234.89 Cr against Rs 156.43 Cr a year earlier, a YoY growth of 50.16%. Net profit was Rs 31.03 Cr against Rs 8.76 Cr in the same quarter last year, up 254.22%. Operating profit also rose, to Rs 42.33 Cr from Rs 8.19 Cr.<\/p>\n<\/div>\n

Ind-Swift Laboratories Ltd<\/a> (INDSWFTLAB) Q2 Results FY27 announced on 29 October 2026, covering the company’s standalone financial performance for the July to September quarter. The company reported revenue of Rs 234.89 Cr and net profit of Rs 31.03 Cr. Ind-Swift Laboratories Q2 Results FY27 are placed here against the same quarter last year, with the results date and the YoY comparison shown together on NSE and BSE.<\/p>\n

This Ind-Swift Laboratories Q2 Results results analysis walks through the standalone financial highlights, the business drivers, the outlook and the risks. The results analysis begins with the table of revenue, operating profit and net profit, so the headline figures sit in one place before each section adds detail.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n